The PEA15 gene is overexpressed and related to insulin resistance in healthy first-degree relatives of patients with type 2 diabetes

Diabetologia

Volumn 49, Issue 12, 2006, Pages 3058-3066

  Valentino, R ^a   Lupoli, G A ^a   Raciti, G A ^a   Oriente, F ^a   Farinaro, E ^b   Della Valle, E ^b   Salomone, M ^b   Riccardi, G ^a   Vaccaro, O ^a   Donnarumma, G ^a   Sesti, G ^c   Hribal, M L ^c   Cardellini, M ^c   Miele, C ^a   Formisano, P ^a   Beguinot, F ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Occupational Medicine Section   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Insulin resistance; PEA15; PED; Type 2 diabetes

Indexed keywords

CHOLESTEROL; GLUCOSE; INSULIN; MESSENGER RNA; PHOSPHOPROTEIN; PHOSPHOPROTEIN ENRICHED IN ASTROCYTES 15; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; FAMILY HISTORY; FEMALE; GENE OVEREXPRESSION; GENETIC ANALYSIS; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RELATIVE; SKELETAL MUSCLE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DNA PRIMERS; FAMILY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INSULIN RESISTANCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PHOSPHOPROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 33750903520     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0455-5     Document Type: Article

References (38)

1. Danziger N, Yokoyama M, Jay T, Cordier J, Glowinski J, Chneiweiss H (1995) Cellular expression, developmental regulation, and phylogenic conservation of PEA-15, the astrocytic major phosphoprotein and protein kinase C substrate. J Neurochem 64:1016-1025
2. Estelles A, Yokoyama M, Nothias F et al (1996) The major astrocytic phosphoprotein PEA-15 is encoded by two mRNAs conserved on their full length in mouse and human. J Biol Chem 271:14800-14806
3. Ramos JW, Hughes PE, Renshaw MW et al (2000) Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism. Mol Biol Cell 11:2863-2872
4. Condorelli G, Vigliotta G, Iavarone C et al (1998) PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. EMBO J 17:3858-3866
5. Formstecher E, Ramos JW, Fauquet M et al (2001) PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev Cell 1:239-250
6. Brunet A, Roux D, Lenormand P, Dowd S, Keyse S, Pouyssegur J (1999) Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J 18:664-674
7. Trencia A, Perfetti A, Cassese A et al (2003) Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action. Mol Cell Biol 23:4511-4521
8. Vaidyanathan H, Ramos JW (2003) RSK2 activity is regulated by its interaction with PEA-15. J Biol Chem 278:32367-32372
9. Estelles A, Charlton CA, Blau HM (1999) The phosphoprotein protein PEA-15 inhibits Fas- but increases TNF-R1-mediated caspase-8 activity and apoptosis. Dev Biol 1999 216:16-28
10. Kitsberg D, Formstecher E, Fauquet M et al (1999) Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis. J Neurosci 19:8244-8251
11. Condorelli G, Vigliotta G, Cafieri A et al (1999) PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis. Oncogene 18:4409-4415
12. Trencia A, Fiory F, Maitan MA et al (2004) Omi/HtrA2 promotes cell death by binding and degrading the anti-apoptotic protein ped/pea-15. J Biol Chem 279:46566-46572
13. Xiao C, Yang BF, Asadi N, Beguinot F, Hao C (2002) Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells. J Biol Chem 277:25020-25025
14. Hao C, Beguinot F, Condorelli G et al (2001) Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apoptosis in human malignant glioma cells. Cancer Res 61:1162-1170
15. Formisano P, Perruolo G, Libertini S et al (2005) Raised expression of the antiapoptotic protein ped/pea-15 increases susceptibility to chemically induced skin tumor development. Oncogene 24:7012-7021
16. Zhang Y, Redina O, Altshuller YM et al (2000) Regulation of expression of phospholipase D1 and D2 by PEA-15, a novel protein that interacts with them. J Biol Chem 275:35224-35232
17. Condorelli G, Vigliotta G, Trencia A et al (2001) Protein kinase C (PKC)-alpha activation inhibits PKC-zeta and mediates the action of PED/PEA-15 on glucose transport in the L6 skeletal muscle cells. Diabetes 50:1244-1252
18. Vigliotta G, Miele C, Santopietro S et al (2004) Overexpression of the PED/PEA-15 gene causes diabetes by impairing glucose-stimulated insulin secretion in addition to insulin action. Mol Cell Biol 24:5005-5015
19. Di Paola R, Frittitta L, Miscio G et al (2002) A variation in 3′ UTR of hPTP1B increases specific gene expression and associates with insulin resistance. Am J Hum Genet 70:806-812
20. Marini MA, Frontoni S, Mineo D et al (2003) The Arg972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients. J Clin Endocrinol Metab 88:3368-3371
21. Genuth S, Alberti KG, Bennett P et al (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160-3167
22. Prudente S, Hribal ML, Flex E et al (2005) The functional Q84R polymorphism of mammalian Tribbles homolog TRB3 is associated with insulin resistance and related cardiovascular risk in Caucasians from Italy. Diabetes 54:2807-2811
23. Cardellini M, Perego L, D'Adamo M et al (2005) C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. Diabetes Care 28:2007-2012
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance nad beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
25. Hanson RL, Pratley RE, Bogardus C et al (2000) Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 151:190-198
26. Metcalfe P, Waters AH (1992) Location of the granulocyte-specific antigen LAN on the Fc-receptor III. Transfus Med 2:283-287
27. Seager Danciger J, Lutz M, Hama S et al (2004) Method for large scale isolation, culture and cryopreservation of human monocytes suitable for chemotaxis, cellular adhesion assays, macrophage and dendritic cell differentiation. J Immunol Methods 288:123-134
28. Miele C, Formisano P, Condorelli G et al (1997) Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects. Diabetologia 40:421-429
29. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
30. Klein BE, Klein R, Moss SE, Cruickshanks KJ (1996) Parental history of diabetes in a population-based study. Diabetes Care 19:827-830
31. Bennet PH (1990) Epidemiology of diabetes mellitus. In: Rifkin H, Porte D Jr (eds) Hellenberg and Rifkin's diabetes mellitus. Elsevier, New York, pp 363-377
32. Condorelli G, Trencia A, Vigliotta G et al (2002) Multiple members of the mitogen-activated protein kinase family are necessary for PED/PEA-15 anti-apoptotic function. J Biol Chem 277:11013-11018
33. Beck-Nielsen H, Groop LC (1994) Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus J Clin Invest 94:1714-1721
34. Eriksson J, Franssila-Kallunki A, Ekstrand A et al (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337-343
35. Knowles NG, Landchild MA, Fujimoto WY, Kahn SE (2002) Insulin and amylin release are both diminished in first-degree relatives of subjects with type 2 diabetes. Diabetes Care 25:292-297
36. Mootha VK, Lingren CM, Eriksson KF et al (2003) PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267-273
37. Subramanian A, Tamayo P, Mootha VK et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545-15550
38. Castillo MJ (2002) Simple assessment of insulin sensitivity and secretion. Int Diabetes Monitor 14:1-7